If patient regular give tab Amlodipine 5mg n suddenly shifted to tab Telmikind.... what s the reaction
Reading File
Finding Sources
Finding Sources
Searching the Web
switching amlodipine to telmisartan abrupt switch reaction blood pressure
Finding Sources
Finding Sources
Reading Web Page
https://www.droracle.ai/articles/380165/do-you-need-to-taper…
Reading File
Finding Sources
I now have enough information to give a comprehensive, clinically relevant answer.
Switching Amlodipine 5mg → Telmikind (Telmisartan 40mg): What to Expect
Telmikind is a brand name for Telmisartan 40mg — an Angiotensin Receptor Blocker (ARB). This is a complete class switch from a Calcium Channel Blocker (CCB) to an ARB. Here is exactly what happens:
🔄 Mechanism Comparison
| Feature | Amlodipine (CCB) | Telmisartan (ARB) |
|---|---|---|
| Class | Dihydropyridine Calcium Channel Blocker | Angiotensin II Receptor Blocker |
| Mechanism | Blocks L-type Ca²⁺ channels → vasodilation | Blocks AT₁ receptors → prevents Ang II vasoconstriction |
| Half-life | ~35–50 hours (very long) | ~24 hours |
| Heart rate effect | Mild reflex tachycardia | Neutral |
| Edema | Yes (ankle/pedal edema common) | No |
⚡ What Happens After Abrupt Switch
1. No Rebound Hypertension (unlike beta-blockers)
Unlike beta-blockers or clonidine, amlodipine does NOT cause rebound hypertension on abrupt discontinuation. Its very long half-life (~35–50 hrs) means the drug tapers itself off naturally over 2–3 days. No tapering is required.
2. Temporary Blood Pressure Gap
- Telmisartan takes 1–2 weeks to reach full antihypertensive effect (ARBs need time to establish steady-state neurohormonal blockade).
- Amlodipine's residual drug will cover the first few days due to its long half-life.
- However, in the day 3–7 window, there may be a transient rise in BP if telmisartan 40mg is insufficient for that patient.
3. Hemodynamic Shift
- Amlodipine causes vasodilation via smooth muscle calcium blockade + mild reflex sympathetic activation.
- Telmisartan works through the RAAS axis. In a patient who was vasodilated on amlodipine, switching may cause mild vasoconstriction temporarily until the ARB's effect is established.
4. Disappearance of Amlodipine-related Side Effects
- Pedal/ankle edema — will resolve within days (this is often why a switch is made).
- Reflex tachycardia/flushing — will resolve.
5. New Side Effect Profile with Telmisartan
- Hyperkalemia risk — especially if the patient has CKD, diabetes, or is on potassium-sparing agents.
- First-dose hypotension — particularly in volume-depleted patients.
- Dry cough is NOT expected (that's ACE inhibitors, not ARBs).
- Angioedema — rare but possible.
⚠️ Clinical Concern: Dose Equivalence
Amlodipine 5mg is a moderate dose CCB. Telmisartan 40mg is a standard starting ARB dose but may not provide equivalent BP control for every patient, especially those with:
- Isolated systolic hypertension
- High-salt diet
- No RAAS activation (where ARBs work best)
If BP was well controlled on Amlodipine 5mg, monitor closely — Telmisartan 40mg may or may not be equivalent for that individual.
✅ Summary
| Concern | Answer |
|---|---|
| Rebound hypertension? | No — amlodipine's long half-life prevents this |
| Tapering needed? | No |
| BP gap possible? | Yes, days 3–10 — monitor BP |
| Edema resolves? | Yes |
| New side effects? | Hyperkalemia, first-dose hypotension |
| Switch safe? | Yes, but monitor BP for 1–2 weeks |
Bottom line: The switch is generally safe and does not require tapering. The main clinical risk is a transient BP control gap in the first 1–2 weeks while telmisartan establishes its effect. Monitor BP closely and consider checking electrolytes (K⁺) after 1–2 weeks, especially in patients with CKD or diabetes.
(Katzung's Basic and Clinical Pharmacology, 16th Edition, p. 283)
This is a shared conversation. Sign in to Orris to start your own chat.